Significant Ownership of Sofinnova Venture Partners X, L.P.

Signature - Title
/s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
Location
Menlo Park, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners X, L.P..

Notify me when Sofinnova Venture Partners X, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sofinnova Venture Partners X, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VERA Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value 4% $128,465,927 2,847,837 Dr. Maha Katabi ("Katabi") 10 Dec 2025
JBIO Jade Biosciences, Inc. Common Stock, par value $0.0001 per share 0.3% $1,617,308 107,391 Sofinnova Venture Partners X, L.P. ("SVP X") 28 Apr 2025

Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.